Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Net Margin (2016 - 2025)

Historic Net Margin for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to 19.8%.

  • Anaptysbio's Net Margin rose 1292400.0% to 19.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 55.92%, marking a year-over-year increase of 2338400.0%. This contributed to the annual value of 159.1% for FY2024, which is 7945500.0% up from last year.
  • Anaptysbio's Net Margin amounted to 19.8% in Q3 2025, which was up 1292400.0% from 173.52% recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Net Margin peaked at 19.8% during Q3 2025, and registered a low of 3237.84% during Q1 2022.
  • Moreover, its 5-year median value for Net Margin was 442.68% (2022), whereas its average is 971.78%.
  • Per our database at Business Quant, Anaptysbio's Net Margin plummeted by -31311500bps in 2021 and then soared by 26323900bps in 2022.
  • Anaptysbio's Net Margin (Quarter) stood at 3075.07% in 2021, then soared by 86bps to 442.68% in 2022, then fell by -6bps to 468.75% in 2023, then soared by 81bps to 87.14% in 2024, then skyrocketed by 123bps to 19.8% in 2025.
  • Its Net Margin stands at 19.8% for Q3 2025, versus 173.52% for Q2 2025 and 141.62% for Q1 2025.